PERSPECTA

News from every angle

← Back to headlines

First Human Trial Begins for Bundibugyo Ebola Vaccine

The first human trial for a vaccine targeting the Bundibugyo variant of Ebola has commenced, with a volunteer in the UK receiving the experimental dose. This marks a significant step in developing protection against this specific Ebola strain.

24 Jul, 21:40 — 24 Jul, 21:40
PostShare

Sources

Showing 1 of 7 sources
Premium TimesMostly Factual3h ago

CEPI begins first human trial of Bundibugyo Ebola vaccine

The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The post CEPI begins first human trial of Bundibugyo Ebola vaccine appeared first on Premium Times Nigeria.

By Agency Report

Read full article →

Coverage Timeline

First report: actualite-cd · 24 Jul, 16:29Full coverage: 7 · 8hWindow: 8h
Left-leaningCenterRight-leaning
actualite-cd24 Jul, 16:29First to report

First Ebola Vaccine Dose Administered to Volunteer - Ratopati

2h later
aftonbladet24 Jul, 18:09

Frivillig försöksperson först med ebolavaccin

iefimerida24 Jul, 18:24

Βρετανία: Πρώτος εθελοντής δοκιμάζει πειραματικό εμβόλιο για το στέλεχος Μπουντιμπούγκιο του Έμπολα

1h later
newsbeast24 Jul, 19:26

Έμπολα: Πρώτος εθελοντής στη Βρετανία έλαβε το εμβόλιο για το στέλεχος Μπουντιμπούγκιο

1h later
n1-bih24 Jul, 20:33

Prvi dobrovoljac primio eksperimentalnu vakcinu protiv ebole

1h later
Premium Times24 Jul, 21:40

CEPI begins first human trial of Bundibugyo Ebola vaccine

2h later
nos25 Jul, 00:03Latest update

Eerste proefpersoon krijgt vaccin tegen Bundibugyo-variant ebola

Related Stories

Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years

just now

Extreme Training: What Heat Training Does to the Body

just now

Veteran Actress Ngozi Nwosu Pleads for N30m for Life-Saving Surgeries

29m ago

Prioritizing Rest as Resistance for Sickle Cell Disease Patients

38m ago